Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4Mouth Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcopenia 2Rectal Neoplasms 2Prostatic Neoplasms 2Liver Cirrhosis 2Kidney Neoplasms 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Skin Lesion 1Penile Neoplasms 1Neoplasms 1Lymphedema 1Lung Neoplasms 1Liver Neoplasms 1Hepatitis B 1Hemangioma, Capillary 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Cerebral Hemorrhage 1Carcinoma, Hepatocellular 1Cachexia 1Brain Neoplasms 1Arteriovenous Malformations 1Aortic Aneurysm, Abdominal 1Adnexal Mass 1

Interventions

Nivolumab 2Magnetic Resonance Spectroscopy 2trastuzumab deruxtecan 1tamibarotene 1cabozantinib 1Ultrasonography 1Specimen Handling 1Ipilimumab 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Urethral Neoplasms × Ultrasonography × Clear all
NCT05899361 2023-10-24

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Dana-Farber Cancer Institute

Phase NA Recruiting
10 enrolled
Genitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urethral Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡